
Stuart Jon Spechler MD
Esophagus Disease
Chief, Division of Gastroenterology Co-Director, Center for Esophageal Diseases Baylor University Medical Center at Dallas Co-Director, Center for Esophageal Research Baylor Scott & White Research Institute
Join to View Full Profile
4500 S Lancaster RdDallas VA Medical CenterDallas, TX 75216
Phone+1 214-857-0403
Fax+1 214-857-1571
Dr. Spechler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stuart Spechler is a gastroenterologist in Dallas, TX and is affiliated with Baylor University Medical Center. He received his medical degree from Boston University School of Medicine and has been in practice 43 years. He specializes in esophagus disease and is experienced in general gastroenterology and esophageal disease. He has more than 300 publications and over 500 citings.
Education & Training
- Boston VA Healthcare System (Brockton-West Roxbury)Fellowship, Gastroenterology, 1977 - 1979
- Boston VA Healthcare System (Brockton-West Roxbury)Residency, Internal Medicine, 1974 - 1977
- Boston University School of MedicineClass of 1974
Certifications & Licensure
- MA State Medical License 1976 - 2027
- TX State Medical License 1999 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow (AGAF) American Gastroenterological Association, 2006
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Clinical Studies on Bile Acids in Barrett's Esophagus Start of enrollment: 2009 Mar 01
- A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors Start of enrollment: 2012 Aug 13
- The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors Start of enrollment: 2007 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsIntegrated Analysis of Vonoprazan Safety for Symptomatic Gastro-Oesophageal Reflux Disease or Erosive Oesophagitis.Colin W Howden, Philip Katz, Kenneth R DeVault, David C Metz, David Tamene
Alimentary Pharmacology & Therapeutics. 2025-03-01 - A Standardized Approach to Performing and Interpreting Functional Lumen Imaging Probe Panometry for Esophageal Motility Disorders: The Dallas Consensus.Dustin A Carlson, John E Pandolfino, Rena Yadlapati, Marcelo F Vela, Stuart J Spechler
Gastroenterology. 2025-02-04 - Functional Lumen Imaging Probe Panometry Findings in Obese Patient Populations.Anh D Nguyen, Anjali Bhatt, Ambreen Merchant, Daisha J Cipher, Ashton Ellison
Neurogastroenterology and Motility. 2025-02-01
Journal Articles
- Can Eosinophilic Esophagitis Cause Achalasia and Other Esophageal Motility Disorders?Stuart Jon Spechler, Rhonda Souza, Nature
Lectures
- Contemporary Review of PPI Therapy: What You and Your Patients Need to KnowAGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/5/2018
- Proton Pump Inhibitors: What the Internist Needs to KnowAmerican Gastroenterological Association (AGA) Institute, San Diego, California - 5/19/2012
Other
- Proton Pump Inhibitors: What the Internist Needs to KnowStuart Spechler, MD, ScienceDirect
https://www.doximity.com/articles/8ad152a3-26a9-43e1-8598-a6a7b947fedd
UpToDate, Wolters Kluwer Health - 2013-04-17 - Proton Pump Inhibitors: What the Internist Needs to KnowStuart Spechler, MD, ScienceDirect
https://www.doximity.com/articles/8ad152a3-26a9-43e1-8598-a6a7b947fedd
UpToDate, Wolters Kluwer Health - 2012-12-18 - Proton Pump Inhibitors: What the Internist Needs to KnowStuart Spechler, MD, ScienceDirect
https://www.doximity.com/articles/8ad152a3-26a9-43e1-8598-a6a7b947fedd
UpToDate, Wolters Kluwer Health - 2012-04-27 - Join now to see all
Press Mentions
- AGA Clinical Practice Update Says P-cABs Can Help When Patients Fail PPI TherapyJanuary 10th, 2025
- Phathom Pharmaceuticals Presents Data on Novel Potassium-Competitive Acid Blocker (PCAB) Vonoprazan from a Range of Studies at Digestive Disease Week® (DDW) 2022May 24th, 2022
- Surgery Helps Tough-to-Treat Acid RefluxJanuary 11th, 2020
- Join now to see all
Grant Support
- Stratification of Cancer Risk in Patients with Non-Dysplastic Barrett's Esophagus using TissueCypher: The SCRiBE studyBAYLOR RESEARCH INSTITUTE2023–2027
- The Role of APE1/Ref-1 in Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Metaplasia: A Novel Target for Preventing Recurrent Barrett's Esophagus After Radiofrequency AblationBAYLOR RESEARCH INSTITUTE2020–2025
- Clinical Studies On Bile Acids In Barrett'S EsophagusVeterans Affairs2011–2012
- Basic And Clinical Studies On The Role Of Bile Acids In Barrett'S EsophagusNational Cancer Institute2009–2012
- Clinical Studies On Bile Acids In Barrett'S EsophagusClinical Science Research &Development2009
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: